/
Ophthalmology
210Diseases↗
1.8KPipeline Programs↗
728Active Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
3,496
clinical trials
Completed1,972 · 56%
Unknown status426 · 12%
Recruiting355 · 10%
Terminated235 · 7%
Active, not recruiting182 · 5%
Not yet recruiting165 · 5%
Other161 · 5%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
Landscape
Diseases
Age-Related Macular Degeneration
Most programs200
Programs
114
Trials
27
Recruiting
Pre
17
P1
58
P2
103
P3
44
Appr
17
Most programs:
Roche
RocheCataract
Most trials150
Programs
38
Trials
34
Recruiting
Pre
55
P1
5
P2
40
P3
44
Appr
83
Most programs:
AbbVie
AbbVieDiabetic Macular Edema
Highest activity130
Programs
51
Trials
18
Recruiting
Pre
24
P1
36
P2
63
P3
42
Appr
21
Most programs:Roche
RocheGlaucoma
4117 programs41 trialsApproved
Macular Degeneration
255 programs86 trialsApproved
Diabetic Retinopathy
279 programs24 trialsApproved
Uveitis
179 programs24 trialsApproved
Retinitis Pigmentosa
153 programs30 trialsApproved
Retinopathy
38 programs44 trialsApproved
Thyroid Eye Disease
234 programs32 trialsApproved
Dry Eye Syndrome
63 programs2 trialsApproved
Myopia
1229 programs30 trialsApproved
Macular Edema
10 programs59 trialsPhase 2
Geographic Atrophy
131 programs27 trialsApproved
Dry Eye
20 programs58 trialsApproved
Conjunctivitis
39 programs9 trialsApproved
Retinal Vein Occlusion
42 programs5 trialsApproved
Open-Angle Glaucoma
138 programs9 trialsApproved
Retinopathy of Prematurity
135 programs8 trialsApproved
Proliferative Diabetic Retinopathy
35 programs8 trialsApproved
Keratitis
31 programs11 trialsApproved
Neovascular Age-Related Macular Degeneration
20 programs42 trialsApproved
Strabismus
33 programs6 trialsApproved
Wet Age-Related Macular Degeneration
33 programs1 trialApproved
Anterior Uveitis
24 programs5 trialsApproved
Blepharitis
26 programs2 trialsApproved
Polypoidal Choroidal Vasculopathy
23 programs5 trialsApproved
Pterygium
125 programs1 trialApproved
Non-Proliferative Diabetic Retinopathy
21 programs5 trialsApproved
Dry Eye Disease
20 programs26 trialsApproved
Showing top 30 diseases by activity. 180 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)